News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Feb / 2026

February 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

« Jan

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Cancer Control in 2036: Science Is Ready — Are We? With Cary Adams

Cancer Control in 2036: Science Is Ready — Are We? With Cary Adams

The Hidden Burden of Chemo Brain: Dr. Arash Asher’s Breakthrough Guidance

The Hidden Burden of Chemo Brain: Dr. Arash Asher’s Breakthrough Guidance

Write to the One You Love: A Valentine’s Invitation from OncoDaily 2026

Write to the One You Love: A Valentine’s Invitation from OncoDaily 2026

Siemens Healthineers and Its Role in Modern Healthcare

Siemens Healthineers and Its Role in Modern Healthcare

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Pat Soon-Shiong: The Next Era of NK and T-Cell Therapies in Oncology

Pat Soon-Shiong: The Next Era of NK and T-Cell Therapies in Oncology

Marzia Zambon: Does Your Country Have a Cost Effectiveness Threshold in Their HTA Evaluation Process?

Marzia Zambon: Does Your Country Have a Cost Effectiveness Threshold in Their HTA Evaluation Process?

𝗠𝗮𝗴𝗻𝗲𝘁® 𝗗𝗲𝘀𝗶𝗴𝗻𝗮𝘁𝗶𝗼𝗻

Mar 28, 2024 1:57 pm

Blog Posts

Dana-Farber Cancer Institute Earns Fifth Consecutive 𝗠𝗮𝗴𝗻𝗲𝘁® Designation

Dana-Farber Cancer Institute Earns Fifth Consecutive 𝗠𝗮𝗴𝗻𝗲𝘁® Designation

Headlines

England’s National Cancer Control Plan 2026: A New Strategic Framework NCP

PATINA Trial: Palbociclib in Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

15 Posts Not To Miss from AMSTRO 2026

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Phase III AMPIRINOX (PRODIGE 98) Trial: Adjuvant mFOLFIRINOX Versus Capecitabine or Gemcitabine in Resected Ampullary Adenocarcinoma

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research ASCO24 colorectal cancer Childhood Cancer clinical trials AACR prostate cancer FDA UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Myeloma NCI Robert Orlowski Vivek Subbiah National Cancer Institute American Society of Clinical Oncology Myeloma Paper of the Day Pancreatic Cancer healthcare Paolo Tarantino radiation oncology cervical cancer AI IASLC ASCO25 WHO Zainab Shinkafi-Bagudu multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}